Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Diabetes management and outcomes among patients with type 2 diabetes attending a renal service
This injection was originally designed for children with pituitary gland dysfunction or other growth restrictions
Warrier, J.M
After about 2 days of treating her with it, her eyes started getting better
There are new breakthroughs in this field all the time, but most of them are currently closely connected
BREAKING NEWS: The Food and Drug Administration (FDA) has approved Gazyva (obinutuzumab) for the treatment of adults living with lupus nephritis, supported by positive Phase II and III trial results
US$ 20.31
US$ 25.92
US$ 27.85
US$ 27.05
US$ 25.54
US$ 21.28
US$ 21.93
